Lytix Biopharma AS
OSE:LYTIX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.68
12.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Lytix Biopharma AS
Total Liabilities & Equity
Lytix Biopharma AS
Total Liabilities & Equity Peer Comparison
HBC
AZT
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
Total Liabilities & Equity
kr63.9m
|
CAGR 3-Years
25%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Hofseth Biocare ASA
OSE:HBC
|
Total Liabilities & Equity
kr385.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
B
|
Bergenbio ASA
OSE:BGBIO
|
Total Liabilities & Equity
kr218.5m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Arcticzymes Technologies ASA
OSE:AZT
|
Total Liabilities & Equity
kr339m
|
CAGR 3-Years
11%
|
CAGR 5-Years
36%
|
CAGR 10-Years
11%
|
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
Total Liabilities & Equity
$179.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
T
|
Thor Medical ASA
OSE:TRMED
|
Total Liabilities & Equity
kr320.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
18%
|
See Also
What is Lytix Biopharma AS's Total Liabilities & Equity?
Total Liabilities & Equity
63.9m
NOK
Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Total Liabilities & Equity amounts to 63.9m NOK.
What is Lytix Biopharma AS's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
2%
Over the last year, the Total Liabilities & Equity growth was -58%. The average annual Total Liabilities & Equity growth rates for Lytix Biopharma AS have been 25% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
